4.5 Editorial Material

Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case

Related references

Note: Only part of the references are listed.
Editorial Material Medicine, General & Internal

The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines

Marco Cavaleri et al.

LANCET (2021)

Article Multidisciplinary Sciences

Vaccinology in the post-COVID-19 era

Rino Rappuoli et al.

Summary: The COVID-19 pandemic highlights the importance of vaccines, with advancements in technology allowing for unprecedented speed in vaccine development. New vaccine technologies accelerated by the urgency of COVID-19 may also hold the key to addressing other health priorities in the post-pandemic world.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Medicine, General & Internal

The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China

Chathika K. Weerasuriya et al.

Summary: The study found that novel TB vaccines could greatly reduce the burden of RR/MDR-TB in the future, while also averting the need for second-line therapy. The cost-effectiveness of vaccination may vary depending on the characteristics of the vaccine and the setting.

BMC MEDICINE (2021)

Review Medicine, General & Internal

New tuberculosis vaccines: advances in clinical development and modelling

C. K. Weerasuriya et al.

JOURNAL OF INTERNAL MEDICINE (2020)

Review Immunology

Transforming vaccine development

Steve Black et al.

SEMINARS IN IMMUNOLOGY (2020)

Review Respiratory System

The global prevalence of latent tuberculosis: a systematic review and meta-analysis

Adam Cohen et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Review Multidisciplinary Sciences

Immunization: vital progress, unfinished agenda

Peter Piot et al.

NATURE (2019)

Article Medicine, General & Internal

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis

D. R. Tait et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Mind the gap: jumping from vaccine licensure to routine use

Katherine L O'Brien et al.

LANCET (2016)

Review Biotechnology & Applied Microbiology

Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines

Rebecca C. Harris et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)

Article Multidisciplinary Sciences

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries

Gwenan M. Knight et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)